Acceder

Farmas USA

136K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
10.208 / 17.019
#81657

Re: Farmas USA

OCAT

Artículo en SA

Since the announcement of the offer, shares have consistently traded within $.10 of the tender price, with the exception a single trading day, indicating a high expected likelihood of completion. However, an online campaign by angry shareholders to turn down the offer has so far been successful and December 17th came and went without Ocata and Astellas able to convince more than 50% of shareholders to accept the offer. Instead of walking away, Astellas decided to extend the $8.50 tender deadline to January 21, 2016.

SEC Disclosure Reveals that Company Has Hired Outside Firm to Push Acquisition.

if the offer falls apart, a management shakeup is likely to be in the cards. The question then becomes whether the remaining shareholders will end up regretting their decision or see a better outcome down the road. Only time will tell.

http://seekingalpha.com/article/3795766-ocata-therapeutics-hires-solicitation-firm-in-bid-to-quell-shareholder-revolt?app=1&auth_param=7ib4d:1b8spoq:c185f3ad5a1f672afa038b00d81916aa&uprof=44#alt1

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#81658

Re: Farmas USA

GALE

Ya están los datos de la oferta

public offering of 19,772,727 units at a public offering price of $1.10 per unit, for total gross proceeds of $21.75 million. Each unit consists of one share of common stock and 0.6 of a warrant to purchase a share of common stock at an exercise price of $1.42 per share. The warrants are immediately exercisable and expire on the fifth anniversary of the date of issuance. The shares of common stock and warrants are immediately separable and will be issued separately.

The offering is expected to close on January 12, 2016, subject to customary closing conditions. Galena has granted the underwriters a 30-day option to purchase up to an additional 2,965,909 shares of common stock and/or additional warrants to purchase up to 1,779,545 shares of common stock to cover over-allotments, if any.

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#81659

Re: Farmas USA

NVAX

Dentro 7,10. Contenta. A medio camino entre mis anteriores precio de entrada y de salida.

Edito: y ahí están obviamente esos 6,8x que tenía planificados, pero bueno...

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#81661

Re: Farmas USA

IBB
Pues nada, que se fue por el desagüe, buff.
NVAX, mínimo 7.01, cualquiera sabe si es capaz de aguantarlos hoy. +buff

#81662

Re: Farmas USA

sp y dj han recuperado pero ibb nada empeora

#81664

Re: Farmas USA

NVAX
Segundo paquete a 6,95. He puesto un tercero a 6,50 pero ya veré si lo muevo durante la sesión un poco al alza.